Price Alert

Virax Biolabs Group Limit... (VRAX)

NASDAQ: VRAX · Real-Time Price · USD

0.61

0.01 (0.93%)

At close: Sep 04, 2025, 3:59 PM

0.62

1.46%

Pre-market: Sep 05, 2025, 09:12 AM EDT

0.93% (1D)

Bid	0.59
Market Cap	2.67M
Revenue (ttm)	84.87K
Net Income (ttm)	-6.58M
EPS (ttm)	-1.62
PE Ratio (ttm)	-0.38
Forward PE	-0.6
Analyst	Buy

Ask	0.61
Volume	170,963
Avg. Volume (20D)	503,133
Open	0.58
Previous Close	0.60
Day's Range	0.58 - 0.64
52-Week Range	0.56 - 4.44
Beta	1.62

About VRAX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol VRAX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for VRAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

10 months ago

+50%

Virax Biolabs shares are trading higher after the ... Unlock content with Pro Subscription

News

5 months ago · benzinga.com

Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating

H.C. Wainwright initiated coverage on Virax Biolabs Group Limited VRAX, a U.K.-based company focused on detecting immune responses and diagnosing viral diseases.